Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure
NCT05909319 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-06-18
Summary
Acute-on-chronic liver failure (ACLF) refers to the acute deterioration of liver function in patients with chronic liver disease. Neutrophils are a major component of the innate immune system, and previous studies have revealed enhanced production of neutrophil extracellular traps (NETs) in ACLF. However, there is still a lack of systematic research on the correlation between NETs and the prognosis of ACLF. We screened NETs related biomarkers through bioinformatics analysis, which play an important role in the diagnosis of ACLF. This study will explore whether these NETs related biomarkers also play an important role in the prognosis of ACLF and further investigate their role in the pathogenesis of ACLF.
Conditions
- Acute-On-Chronic Liver Failure
Sponsors & Collaborators
-
First Affiliated Hospital of Wenzhou Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-25
- Primary Completion
- 2024-12-25
- Completion
- 2025-06-25
More Related Trials
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02038387 ·Status: UNKNOWN ·Phase: NA
-
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414 ·Status: COMPLETED
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital
NCT06601361 ·Status: NOT_YET_RECRUITING
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
The Role of Immune Semaphorins in NAFLD
NCT04573543 ·Status: COMPLETED
-
Study of New Biological Markers for Prediction of Severe Acute Pancreatitis
NCT00786591 ·Status: COMPLETED
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
NCT00610597 ·Status: COMPLETED
-
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
NCT05859633 ·Status: UNKNOWN
-
S100A8/A9 and Innate Immunity in Liver Disease
NCT05793983 ·Status: UNKNOWN
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection
NCT05276700 ·Status: UNKNOWN
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
NCT05131594 ·Status: ENROLLING_BY_INVITATION
-
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NCT03773887 ·Status: RECRUITING ·Phase: NA
-
Study of the Clinical Features of Autoimmune Hepatitis
NCT02994537 ·Status: UNKNOWN
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
COVID-19 and Nonalcoholic Fatty Liver Disease
NCT04982328 ·Status: COMPLETED